文献
J-GLOBAL ID:201702259396814025
整理番号:17A1499777
進行卵巣癌患者における初回治療としての高用量パクリタキセルとベバシズマブの第II相試験【Powered by NICT】
Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer
著者 (9件):
Fleming Nicole D.
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Coleman Robert L.
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Tung Celestine
(Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States)
,
Westin Shannon N.
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Hu Wei
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Sun Yunjie
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Bhosale Priya
(Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Munsell Mark F.
(Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
,
Sood Anil K.
(Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
147
号:
1
ページ:
41-46
発行年:
2017年
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)